Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it has entered into an agreement ...

Guardant Health, Inc. (NASDAQ:GH – Get Free Report) has been assigned an average rating of “Buy” from the twenty analysts that are currently covering the stock, MarketBeat reports. Twenty analysts ...

The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.

BTIG analyst Mark Massaro reiterated a Buy rating on Guardant Health (GH – Research Report) yesterday and set a price target of $60.00. The ...

SAN ANTONIO — March may have been colorectal cancer awareness month, but the need to get more people screened is year round. In tonight's Healthy SA we took a look at a new blood test for the disease, ...

Guardant Health (GH) “announced its Shield blood test for colorectal cancer screening is now covered by a key healthcare insurance program for ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Blandine Merino is a seasoned executive with over 20 years of experience driving product development, business operations, and strategy at companies like Guardant Health, Freenome, and Agilent. She ...

Personal health and wellness is one of the many secular tailwinds for healthcare companies. But financial performance has lagged recently as players offloaded surplus COVID inventories in 2023 and ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...